Novel biomarkers, including neurofilament light (NFL), glial fibrillary acidic protein (GFAP), total-tau, and phosphorylated tau, have shown promising prognostic value after cardiac arrest [3–12]. The gene discussed is GFAP; the disease is cardiac arrest.